← Back to headlines
Boston Scientific (BSX) Faces WATCHMAN Slowdown, Analysts Still See Upside
Boston Scientific (BSX) is experiencing a slowdown in its WATCHMAN device sales. Despite this, analysts continue to see potential upside for the company's stock.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Frankfurt Airport Worker Dies After Contracting Malaria On Site
19m ago
Magician and TV Host Durek Verrett Undergoes Kidney Transplant
21m ago
Busy Philipps Diagnosed With Rare Brain Tumor After Health Scare
24m ago
Closing Arguments Approach in Murder Trial of Man Accused in Lindsay Clancy’s Death
42m ago